Clinigen

Activities: Regulatory

Trending Articles

  1. IFF Pharma Solutions launches customer experience platform, AnswerCenter AnswerCenter is part of IFF's ongoing digitalisation initiative, allowing customers to easily access tailored pharmaceutical excipient solutions
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to...
  3. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...
  4. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation...
  5. TekniPlex Healthcare to showcase expanded capacity and sustainability solutions at Pharmapack Company highlights EU-based advancements in injection blow molding, multilayer blown films, and sustainable blister packaging

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Finance

Clinigen expands Accord partnership into France

Earlier this year, Clinigen’s Global Access Business also extended its partnership with Accord for a further five years
Manufacturing

Porton Biopharma Limited licenses Erwinase to Clinigen

The new contract with Clinigen will begin on 1 January 2021
Packaging

Packaging for success

Somewhat misguidedly, pharmaceutical packaging is often overlooked or assumed to be a commodity service that “anyone can do,” says Scott Houlton, CEO, CSM (a Clinigen Group company)
Media

Clinigen strengthens senior management team

Media

Clinigen acquires Japan’s largest supplier of unlicensed medicines

Clinigen Group, a global pharmaceutical and services company, has acquired International Medical Management Corporation, Japan’s largest supplier of unlicensed medicines, for an undisclosed sum

AI and CAH patients can access unlicensed medicines

Clinigen and Diurnal partner up for European Managed Access programme for Infacort and Chronocort
Distribution

Clinigen and BTG extend global partnership with new exclusive Global Access agreement

Agreement extends the 4-year partnership Clinigen has with BTG to provide early access programmes
Subscribe now